Have commercially manufactured axicabtagene ciloleucel that does not meet commercial release criteria but does meet Kite clinical trial release criteria
Females of childbearing potential must have a negative serum or urine pregnancy test (females who have undergone surgical sterilization or who have been post-menopausal for at least 2 years are not considered to be of childbearing potential)
Deemed medically fit and stable to receive the product per the investigator's evaluation
Repeat leukapheresis is not feasible per the investigator's assessment
Be diagnosed with 1 of the approved labeled indications for axicabtagene ciloleucel that is intended for release
In the investigator's opinion, there is no satisfactory alternative therapy available to the individual
You may not be if
History of severe immediate hypersensitivity to any drugs or metabolites of similar chemical classes as axicabtagene ciloleucel
Uncontrolled active infection or inflammation per physician assessment
